Stocktoria

Quanterix Corp QTRX

Nasdaq · XNAS · stock · Laboratory Analytical Instruments
Chart by TradingView
1/9
Piotroski F — financial health
-1.83
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials (annual, from 10-K)

FYRevenueNet incomeGross profitFree cash flowEquity
2025$138.9M-$107.2M$65.0M-$79.8M$295.7M
2024$137.4M-$38.5M$83.1M-$38.5M$330.0M
2023$122.4M-$28.4M$74.2M-$22.7M$350.0M
2022$105.5M-$99.6M$45.4M-$60.2M$357.9M
2021$110.6M-$57.7M$61.7M-$61.5M$442.8M
2020$86.4M-$31.5M$48.2M-$27.3M$206.1M

Recent insider activity (Form 4)

InsiderRoleDateActionSharesPrice
Sriram VandanaChief Financial Officer2026-06-15Tax withheld79$3.10
Sriram VandanaChief Financial Officer2026-06-15Option exercise514
Sriram VandanaChief Financial Officer2026-06-15Tax withheld154$3.10
Sriram VandanaChief Financial Officer2026-06-15Option exercise1,056
Sriram VandanaChief Financial Officer2026-06-15Tax withheld315$3.10
Miller Michael FrancisChief Technology Officer2026-06-15Option exercise81
Miller Michael FrancisChief Technology Officer2026-06-15Tax withheld25$3.10
Sriram VandanaChief Financial Officer2026-06-15Option exercise263

Why these scores methodology →

Piotroski F-score: 1/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -1.83 (distress)

  • Working capital / assets 0.328
  • Retained earnings / assets -1.378
  • EBIT / assets -0.3
  • Equity / liabilities 2.404

Source: SEC EDGAR filings · CIK 0001503274 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.